WASHINGTON DC – GigaGen Inc. participated in Steve Blank’s inaugural Lean LaunchPad for the National Cancer Institute at the National Institutes of Health. The Lean LaunchPad program has been profiled in Harvard Business Review, and is now a core part of entrepreneurship programs at business schools such as Stanford GSB and Berkeley-Haas School of Business. GigaGen interviewed a record 163 customers and stakeholders to assess the viability of their preclinical recombinant gammaglobulin product. As part of the program, GigaGen’s CEO traveled to Prague, Czech Republic, for the worldwide meeting of the European Society for Immune Deficiency, where he met with dozens of physicians, nurses, and patients. GigaGen also spoke with FDA, recombinant protein producers, plasma product companies, and the Immune Deficiency Foundation.